HomeXBIT • NASDAQ
add
XBiotech Inc
Nakaraang pagsara
$2.41
Sakop ng araw
$2.30 - $2.40
Sakop ng taon
$2.09 - $7.24
Market cap
72.23M USD
Average na Volume
150.95K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 6.05M | -23.49% |
Net na kita | -6.01M | -19.80% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | -5.62M | 24.72% |
Aktuwal na % ng binabayarang buwis | -1.73% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 147.37M | -19.52% |
Kabuuang asset | 172.42M | -17.84% |
Kabuuang sagutin | 5.34M | -69.87% |
Kabuuang equity | 167.08M | — |
Natitirang share | 30.49M | — |
Presyo para makapag-book | 0.44 | — |
Return on assets | -8.61% | — |
Return on capital | -8.89% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -6.01M | -19.80% |
Cash mula sa mga operasyon | -4.26M | 27.13% |
Cash mula sa pag-invest | -110.00K | 67.46% |
Cash mula sa financing | 0.00 | -100.00% |
Net change in cash | -5.57M | -2.94% |
Malayang cash flow | -3.36M | 39.41% |
Tungkol
XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases. Wikipedia
Itinatag
2005
Headquarters
Website
Mga Empleyado
88
